Learning the lessons of COVID-19: Protecting cancer services and research through the pandemic
It's going to be a tough winter for all of us.
Nov 10, 2020
0
3
It's going to be a tough winter for all of us.
Nov 10, 2020
0
3
Cancer Research UK scientists have invented a new experimental drug that aims to harness the full power of the body's own immune system, launching a two-pronged response against cancer, according to a study published in Nature ...
Nov 10, 2020
0
147
Some people with head and neck cancer will now have access to the immunotherapy drug pembrolizumab (Keytruda) on the NHS in England.
Oct 27, 2020
0
3
Earlier detection of cancer offers arguably the single biggest opportunity to save lives from the disease, but there are many challenges of seeing this a reality for patients in the NHS, according to Cancer Research UK's ...
Oct 6, 2020
0
2
PARP inhibitors are rapidly transforming the treatment of ovarian, breast, prostate and other types of cancer. To develop these drugs, researchers supported by Cancer Research UK had to decipher how blocking DNA repair could ...
Sep 25, 2020
0
22
At least 14,000 fewer people have been urgently referred for lung cancer tests since March.
Sep 18, 2020
0
2
It's been six months since the UK entered lockdown.
Sep 14, 2020
0
3
In two decisions published today, the National Institute for Health and Care Excellence (NICE) has approved the drug osimertinib (Tagrisso) to treat some adults in England with advanced lung cancer whose cancer tests positive ...
Sep 14, 2020
0
6
A drug combination for people with a rare type of bowel cancer has received an initial rejection from the National Institute for Health and Care Excellence (NICE).
Sep 7, 2020
0
3
Researchers at the Cancer Research UK-AstraZeneca Antibody Alliance Laboratory in Cambridge, UK, have pioneered the development of an innovative affinity maturation technique to generate an inhibitory, high-affinity antibody ...
Sep 4, 2020
0
91